Personal tools

MCL coexpression mm9:1480: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0004121!1.38e-21!95;UBERON:0000924!1.38e-21!95;UBERON:0006601!1.38e-21!95;UBERON:0001017!4.91e-20!73;UBERON:0010371!2.38e-19!73;UBERON:0001016!4.09e-19!75;UBERON:0000073!1.09e-18!54;UBERON:0001049!1.45e-17!52;UBERON:0005068!1.45e-17!52;UBERON:0006241!1.45e-17!52;UBERON:0007135!1.45e-17!52;UBERON:0002346!2.34e-16!64;UBERON:0003075!2.34e-16!64;UBERON:0007284!2.34e-16!64;UBERON:0002020!9.86e-15!34;UBERON:0000955!3.34e-14!47;UBERON:0006238!3.34e-14!47;UBERON:0002616!8.28e-14!46;UBERON:0010314!1.42e-12!92;UBERON:0003080!6.37e-12!40;UBERON:0003056!8.66e-12!49;UBERON:0003528!1.91e-11!29;UBERON:0002791!1.91e-11!29;UBERON:0001893!1.91e-11!29;UBERON:0002780!2.28e-11!39;UBERON:0001890!2.28e-11!39;UBERON:0006240!2.28e-11!39;UBERON:0000468!1.02e-08!333;UBERON:0000956!2.18e-07!21;UBERON:0001869!2.18e-07!21;UBERON:0000203!2.18e-07!21
|ontology_enrichment_uberon=UBERON:0004121!1.38e-21!95;UBERON:0000924!1.38e-21!95;UBERON:0006601!1.38e-21!95;UBERON:0001017!4.91e-20!73;UBERON:0010371!2.38e-19!73;UBERON:0001016!4.09e-19!75;UBERON:0000073!1.09e-18!54;UBERON:0001049!1.45e-17!52;UBERON:0005068!1.45e-17!52;UBERON:0006241!1.45e-17!52;UBERON:0007135!1.45e-17!52;UBERON:0002346!2.34e-16!64;UBERON:0003075!2.34e-16!64;UBERON:0007284!2.34e-16!64;UBERON:0002020!9.86e-15!34;UBERON:0000955!3.34e-14!47;UBERON:0006238!3.34e-14!47;UBERON:0002616!8.28e-14!46;UBERON:0010314!1.42e-12!92;UBERON:0003080!6.37e-12!40;UBERON:0003056!8.66e-12!49;UBERON:0003528!1.91e-11!29;UBERON:0002791!1.91e-11!29;UBERON:0001893!1.91e-11!29;UBERON:0002780!2.28e-11!39;UBERON:0001890!2.28e-11!39;UBERON:0006240!2.28e-11!39;UBERON:0000468!1.02e-08!333;UBERON:0000956!2.18e-07!21;UBERON:0001869!2.18e-07!21;UBERON:0000203!2.18e-07!21
|tfbs_overrepresentation_for_novel_motifs=0.491922,1.24447,3.03136,0.535892,0.346849,0.550971,1.55624,0.247459,0.7141,2.6668,0.599767,0.632897,0.247704,0.6581,0.364314,0,1.99389,0.338549,1.22315,0.86893,0.426133,0.35122,0.657163,0.345236,2.0696,0.686615,1.85593,0.572827,0.394364,0.181062,1.37295,0.960397,0.336199,1.11492,0.364821,0.0363535,4.26527,0.629145,0.303703,0.27383,0.342638,1.38433,0.0995018,0.366415,1.02402,0.524258,0.77511,0.589246,0.0835644,1.02809,0.839084,0.714419,0.174327,1.10437,1.12205,0.66551,0.406788,0.619643,0.21472,0.663395,0.939962,0.724164,0.742129,0.827522,3.96901,0.869046,1.2599,1.61148,0.935192,1.46355,1.1311,0.253541,3.09546,1.156,2.50016,1.70884,0.204132,0.763395,0.922432,0.430551,0.708505,0.874787,0.722675,0.240896,3.86445,4.08047,0.827903,1.02367,0.780154,1.77427,1.33021,1.04409,0.973447,0.35304,1.47187,0.281222,0.244935,0.976308,0.775372,0.483322,0.326561,0.960112,1.08669,0.839694,0.838613,0.563071,0.8998,0.585058,0.435642,0.428007,2.10971,1.0885,0.431734,0.605144,1.33732,0.340765,1.35637,0.53982,0.858327,0.322606,1.16147,0.805995,0.688501,0.762461,1.39185,0.926209,0.65384,0.966541,1.25836,1.67297,1.06946,1.30967,1.2285,0.679647,1.35909,0.106956,0.500709,0.564999,1.30952,2.14327,1.74232,1.26465,0.700956,0.971067,0.831964,0.564002,0.778321,2.10357,0.503174,0.348692,3.08554,1.10885,1.10596,0.287383,0.678689,1.18867,2.85697,0.376898,0.48935,0.500417,1.31911,1.03816,0.926663,0.482185,0.82857,0.671017,0.325308,0.63125,6.876
}}
}}

Revision as of 19:58, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr7:80520366..80520378,+p5@Rgma
Mm9::chr7:80520380..80520435,+p2@Rgma
Mm9::chr7:80520452..80520464,+p3@Rgma
Mm9::chr7:80520471..80520483,+p6@Rgma
Mm9::chr7:80520608..80520630,-p1@ENSMUST00000167076
Mm9::chr7:80520700..80520719,+p4@Rgma


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0001843neural tube closure0.0164972881170219
GO:0014020primary neural tube formation0.0164972881170219
GO:0001841neural tube formation0.0164972881170219
GO:0001839neural plate morphogenesis0.0164972881170219
GO:0001838embryonic epithelial tube formation0.0164972881170219
GO:0001840neural plate development0.0164972881170219
GO:0021915neural tube development0.0164972881170219
GO:0016331morphogenesis of embryonic epithelium0.0164972881170219
GO:0048503GPI anchor binding0.0213144486702979
GO:0002009morphogenesis of an epithelium0.0213144486702979
GO:0035239tube morphogenesis0.0213144486702979
GO:0035091phosphoinositide binding0.0213144486702979
GO:0009986cell surface0.0213144486702979
GO:0005543phospholipid binding0.0213144486702979
GO:0048598embryonic morphogenesis0.0213144486702979
GO:0035295tube development0.0213144486702979
GO:0016337cell-cell adhesion0.0213144486702979
GO:0043009chordate embryonic development0.0213144486702979
GO:0009792embryonic development ending in birth or egg hatching0.0213144486702979
GO:0008289lipid binding0.0321810113406015
GO:0009790embryonic development0.0384829108326616
GO:0022610biological adhesion0.0462199185839612
GO:0007155cell adhesion0.0462199185839612
GO:0007399nervous system development0.0465539911247466



Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
ectoderm-derived structure1.38e-2195
ectoderm1.38e-2195
presumptive ectoderm1.38e-2195
central nervous system4.91e-2073
ecto-epithelium2.38e-1973
nervous system4.09e-1975
regional part of nervous system1.09e-1854
neural tube1.45e-1752
neural rod1.45e-1752
future spinal cord1.45e-1752
neural keel1.45e-1752
neurectoderm2.34e-1664
neural plate2.34e-1664
presumptive neural plate2.34e-1664
gray matter9.86e-1534
brain3.34e-1447
future brain3.34e-1447
regional part of brain8.28e-1446
structure with developmental contribution from neural crest1.42e-1292
anterior neural tube6.37e-1240
pre-chordal neural plate8.66e-1249
brain grey matter1.91e-1129
regional part of telencephalon1.91e-1129
telencephalon1.91e-1129
regional part of forebrain2.28e-1139
forebrain2.28e-1139
future forebrain2.28e-1139
multi-cellular organism1.02e-08333
cerebral cortex2.18e-0721
cerebral hemisphere2.18e-0721
pallium2.18e-0721


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}